BE863359A - Nouvelles glycoproteines isolees d'hafnia, procede de preparation et compositions pharmaceutiques - Google Patents

Nouvelles glycoproteines isolees d'hafnia, procede de preparation et compositions pharmaceutiques

Info

Publication number
BE863359A
BE863359A BE184666A BE184666A BE863359A BE 863359 A BE863359 A BE 863359A BE 184666 A BE184666 A BE 184666A BE 184666 A BE184666 A BE 184666A BE 863359 A BE863359 A BE 863359A
Authority
BE
Belgium
Prior art keywords
hafnia
preparation
pharmaceutical compositions
glycoproteins isolated
new glycoproteins
Prior art date
Application number
BE184666A
Other languages
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of BE863359A publication Critical patent/BE863359A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/275—Hafnia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BE184666A 1977-01-27 1978-01-26 Nouvelles glycoproteines isolees d'hafnia, procede de preparation et compositions pharmaceutiques BE863359A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7702267A FR2378855A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments

Publications (1)

Publication Number Publication Date
BE863359A true BE863359A (fr) 1978-07-26

Family

ID=9185964

Family Applications (1)

Application Number Title Priority Date Filing Date
BE184666A BE863359A (fr) 1977-01-27 1978-01-26 Nouvelles glycoproteines isolees d'hafnia, procede de preparation et compositions pharmaceutiques

Country Status (12)

Country Link
US (1) US4154821A (fr)
JP (1) JPS5396000A (fr)
BE (1) BE863359A (fr)
CA (1) CA1092041A (fr)
CH (1) CH639395A5 (fr)
DE (1) DE2803001A1 (fr)
DK (1) DK150497C (fr)
FR (1) FR2378855A1 (fr)
GB (1) GB1567106A (fr)
IE (1) IE46195B1 (fr)
LU (1) LU78953A1 (fr)
NL (1) NL7801024A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4313934A (en) * 1979-05-08 1982-02-02 Kirin Beer Kabushiki Kaisha Physiologically active polysaccharides, production and uses thereof
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
US4503149A (en) * 1983-06-06 1985-03-05 Conoco Inc. Method of microbial assay
FR2563431B1 (fr) * 1984-04-26 1987-03-06 Roussel Uclaf Nouvelles compositions cosmetiques renfermant des extraits lyses d'hafnia
FR2648351A1 (fr) * 1989-06-20 1990-12-21 Roussel Uclaf Utilisation de complexes glycoproteiques extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau et procede de preparation
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1046770A (en) * 1963-05-14 1966-10-26 James Harrison Stanton Therapeutic composition containing mycelial matter
GB1186184A (en) * 1966-03-23 1970-04-02 Nat Res Dev Improvements in or relating to Separation Apparatus.
US3855197A (en) * 1969-05-20 1974-12-17 Cassenne Lab Sa Glycoproteins extracted from microorganisms
US3716452A (en) * 1970-09-17 1973-02-13 Kirin Brewery Lysis of yeast cell walls
FR2160326B1 (fr) * 1971-11-19 1975-02-07 Anvar
GB1426042A (en) * 1971-11-26 1976-02-25 Anvar water-soluble immunological adjuvants
US4032663A (en) * 1971-12-14 1977-06-28 Kumiai Chemical Industry Co., Ltd. Process for using cell wall-lysing enzymes
FR2184531B1 (fr) * 1972-05-19 1975-10-17 Anvar
US3868303A (en) * 1972-11-06 1975-02-25 Nat Food Res Method of producing enzyme and its utilization thereof
US3917510A (en) * 1973-04-11 1975-11-04 Kirin Brewery Lysis of yeast cell walls
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2269961B1 (fr) * 1974-05-06 1978-03-24 Anvar

Also Published As

Publication number Publication date
US4154821A (en) 1979-05-15
LU78953A1 (fr) 1978-09-28
JPS5396000A (en) 1978-08-22
CA1092041A (fr) 1980-12-23
DK150497B (da) 1987-03-09
IE46195B1 (en) 1983-03-23
DE2803001C2 (fr) 1990-07-05
FR2378855B1 (fr) 1979-05-11
DK37578A (da) 1978-07-28
CH639395A5 (fr) 1983-11-15
IE780183L (en) 1978-07-27
NL7801024A (nl) 1978-07-31
FR2378855A1 (fr) 1978-08-25
JPS6133840B2 (fr) 1986-08-04
DE2803001A1 (de) 1978-08-03
GB1567106A (en) 1980-05-08
DK150497C (da) 1987-11-16

Similar Documents

Publication Publication Date Title
BE847742A (fr) Nouvelles imidazolidines, procede de preparation et compositions pharmaceutiques
DE2961740D1 (en) N-heterocyclyl-4-piperidinamines, methods for their preparation, pharmaceutical compositions comprising them, intermediates therefor, and method for the preparation of the intermediates
PH17552A (en) Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolines,their pharmaceutical compositions and method of use
BE890192A (fr) Compositions et procede pharmaceutiques
NL930110I1 (nl) Carbazolyl-(4)-oxypropanolamine-derivaten werkwijze ter bereiding daarvan en geneesmiddelen die dezeverbindingen bevatten
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
BE868417A (fr) Derives d'acide 1,2,3-thiadiazole-5-carboxylique leur procede de preparation et leur utilisation
DE2862419D1 (en) Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
IT1128637B (it) Procedimento ed apparecchio per l'estrazione di componenti oleosi da soluzioni di sodio laurilsolfato
BE862870A (fr) Nouveaux derives steroides 11 beta-substitues 1,3,5(10)-trieniques, procede de preparation et compositions pharmaceutiques
BE863359A (fr) Nouvelles glycoproteines isolees d'hafnia, procede de preparation et compositions pharmaceutiques
BE864173A (fr) Nouveaux derives de 20,21-dinoreburnamenine, procede de preparation et compositions pharmaceutiques
BE863082A (fr) Nouvelles imidazoquinoleines et leurs sels, procede de preparation et compositions pharmaceutiques
BE872109A (fr) Nouvelles imidazobenzoxazines et leurs sels, procede de preparation et compositions pharmaceutiques
BE865917A (fr) Nouvelles pyrroloquinoxalines et leurs sels, procede de preparation et compositions pharmaceutiques
FR2305416A1 (fr) Procede de preparation de tricosene-(9) et d'heneicosene-(9)
PT71495A (fr) Procede d'obtention d'extraits de lierre grimpant et de compositions pharmaceutiques qui en contiennent
BE879990A (fr) Nouvelles triazionones et triazine-thiones substituees et procede de preparation
SE7810895L (sv) Framstellning av 6,11-dihydro-11-oxodibens(b,e)-oxepin-2-ettiksyra och mellanprodukter herfor
ZA784501B (en) Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof
FR2304603A1 (fr) Nouvelles 2,3-dihalogeno-alcanoyl-urees, leur procede de preparation et leur application comme fongicides
PH15364A (en) 5,3-disubstituted 1h 1,2,4-thiazole derivatives their pharmaceutical compositions and method of use
NL7802525A (nl) Vast farmaceutisch preparaat en werkwijze ter bereiding daarvan.
NL7809647A (nl) 2-oxazolidon-derivaten en de bereidingswijze daarvan.
PH14064A (en) Phenylgycine derivatives,pharmaceutical compositions and method of use

Legal Events

Date Code Title Description
CA Change of address of the owner of the patent
RE20 Patent expired

Owner name: ROUSSEL UCLAF

Effective date: 19980126